Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome

Objectives To determine the prevalence of autonomic dysfunction (dysautonomia) among patients with primary Sjögren's syndrome (PSS) and the relationships between dysautonomia and other clinical features of PSS. Methods Multicentre, prospective, cross-sectional study of a UK cohort of 317 patien...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2012-12, Vol.71 (12), p.1973-1979
Hauptverfasser: Newton, Julia L, Frith, James, Powell, Danielle, Hackett, Kate, Wilton, Katharine, Bowman, Simon, Price, Elizabeth, Pease, Colin, Andrews, Jacqueline, Emery, Paul, Hunter, John, Gupta, Monica, Vadivelu, Saravanan, Giles, Ian, Isenberg, David, Lanyon, Peter, Jones, Adrian, Regan, Marian, Cooper, Annie, Moots, Robert, Sutcliffe, Nurhan, Bombardieri, Michele, Pitzalis, Costantino, McLaren, John, Young-Min, Steven, Dasgupta, Bhaskar, Griffiths, Bridget, Lendrem, Dennis, Mitchell, Sheryl, Ng, Wan-Fai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To determine the prevalence of autonomic dysfunction (dysautonomia) among patients with primary Sjögren's syndrome (PSS) and the relationships between dysautonomia and other clinical features of PSS. Methods Multicentre, prospective, cross-sectional study of a UK cohort of 317 patients with clinically well-characterised PSS. Symptoms of autonomic dysfunction were assessed using a validated instrument, the Composite Autonomic Symptom Scale (COMPASS). The data were compared with an age- and sex-matched cohort of 317 community controls. The relationships between symptoms of dysautonomia and various clinical features of PSS were analysed using regression analysis. Results COMPASS scores were significantly higher in patients with PSS than in age- and sex-matched community controls (median (IQR) 35.5 (20.9–46.0) vs 14.8 (4.4–30.2), p
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2011-201009